BC tumor microenvironment (TME) is composed of a diverse population of innate and adaptive immune system cells, and HER2-positive tumors with high genomic instability and tumor mutation burden (TMB) exhibit the highest levels of immune infiltration, which in turn is associated with a high level of tumor-infiltrating lymphocytes (TILs). Here, ERBB2 is linked to breast cancer.